How Do Two Armenian Citizens Infected with the Omicron Variant Feel?

Two Armenian citizens infected with the Omicron variant are experiencing mild symptoms, which is why they are receiving treatment in home settings. This information was shared during a press conference by Romela Abovyan, head of the Department of Hospital Infections Epidemiology at the National Center for Disease Control and Prevention of Armenia.

According to her, one of the individuals infected with the Omicron variant arrived in Armenia from the USA via Moscow, while the other came from Egypt.

“In our country, regardless of the type of variant, the same procedure is followed, meaning that individuals with a positive PCR test are subject to self-isolation for a duration of 14 days. Based on the severity of the clinical course of the disease, a decision is made on whether the patient will receive treatment at home or will be hospitalized,” Abovyan stated.

Like other variants, Omicron spreads rapidly. To prevent this, the third booster vaccination is more effective. Scientific research shows that it increases immunity and fights against Omicron.

Abovyan also noted that the existence of the Delta Kron variant has not yet been confirmed, making discussions about its spread in Armenia pointless. She reminded that only the variants reported by the WHO have been detected in the country.

Commenting on the situation regarding coronavirus infections in the country, Abovyan mentioned that it remains stable for now. The reproductive rate of the coronavirus is currently below 1; however, there is a risk of a more active spread and an increase in detected cases.

“We predict an increase in coronavirus infection cases, which is conditioned by several factors, including the reopening of schools and universities, and the holding of various festive events,” Abovyan said.

She emphasized that currently, Armenia remains in the green zone according to EU standards.

It is noted that unlike the Delta variant, the Omicron variant spreads much more quickly but is relatively mild in clinical course, primarily affecting the upper respiratory tract, accompanied by nasal discharge and throat pain, and rarely causing pneumonia. Unlike other variants, children are more vulnerable to the Omicron variant.